The National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Biomarkers Program (PDBP) was developed to accelerate the discovery of promising new diagnostic and progression biomarkers for Parkinson's Disease.
Who we are

Who we are

The Parkinson's Disease Biomarkers Program (PDBP) is made up of researchers, patients, family members, and healthcare professionals who are dedicated to accelerating the pace of biomarkers research.

What is a biomarker?

A biomarker, or biological marker, is a measurable attribute in a living person that indicates a disease, disease subtype, exposure, or risk. Examples of biomarkers for other diseases include cholesterol levels for heart disease and blood pressure for heart disease or stroke risk. No biomarkers currently exist for PD or related diseases.

The PDBP will serve as a multi-faceted platform for:


Integrating existing biomarker efforts


Standardizing data collection and management across these efforts


Accelerating the discovery of new biomarkers


Fostering and expanding collaborative opportunities for all stakeholders